Simplex Trading
PHIO icon

Simplex Trading’s Phio Pharmaceuticals PHIO Stock Holding History

Simplex Trading’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4
Closed -$303 – 10651
2022
Q2 		$0 Buy
+4
New +$376 ﹤0.01% 10817
2016
Q1 		– Hold
0
– – – 6076
2015
Q4 		– Hold
0
– – – 5957
2015
Q3 		– Hold
0
– – – 6030
2015
Q2 		– Hold
0
– – – 5696
2015
Q1 		– Hold
0
– – – 5440

Other funds holding PHIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Simplex Trading's PHIO Position: Q3 2022 in Review

Simplex Trading sold out of Phio Pharmaceuticals (PHIO) in Q3 2022, closing a stake of 4 shares — an estimated $303 sold.

Simplex Trading first reported a position in PHIO in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 14 funds tracked by Wall St. Rank hold PHIO as of Q3 2022.

  • Simplex Trading reported no remaining Phio Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 4 Phio Pharmaceuticals shares in Q3 2022, an estimated $303.
  • Simplex Trading first reported a position in Phio Pharmaceuticals in Q2 2022 and held it in 1 quarter.
  • Simplex Trading's Phio Pharmaceuticals position peaked at $0 in Q2 2022.
  • 14 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.